| Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage L Schwab, L Goroncy, S Palaniyandi, S Gautam, A Triantafyllopoulou, ... Nature medicine 20 (6), 648-654, 2014 | 299 | 2014 |
| Pseudomonas Exotoxin A: optimized by evolution for effective killing M Michalska, P Wolf Frontiers in microbiology 6, 151249, 2015 | 292 | 2015 |
| Pseudomonas exotoxin A: from virulence factor to anti-cancer agent P Wolf, U Elsässer-Beile International Journal of Medical Microbiology 299 (3), 161-176, 2009 | 229 | 2009 |
| Androgen deprivation of prostate cancer: Leading to a therapeutic dead end A Katzenwadel, P Wolf Cancer letters 367 (1), 12-17, 2015 | 154 | 2015 |
| PET imaging of prostate cancer xenografts with a highly specific antibody against the prostate-specific membrane antigen U Elsässer-Beile, G Reischl, S Wiehr, P Bühler, P Wolf, K Alt, J Shively, ... Journal of Nuclear Medicine 50 (4), 606-611, 2009 | 137 | 2009 |
| Targeted therapies for prostate cancer against the prostate specific membrane antigen U Elsasser-Beile, P Buhler, P Wolf Current drug targets 10 (2), 118-125, 2009 | 137 | 2009 |
| A bispecific diabody directed against prostate-specific membrane antigen and CD3 induces T-cell mediated lysis of prostate cancer cells P Bühler, P Wolf, D Gierschner, I Schaber, A Katzenwadel, ... Cancer Immunology, Immunotherapy 57, 43-52, 2008 | 116 | 2008 |
| A new generation of monoclonal and recombinant antibodies against cell‐adherent prostate specific membrane antigen for diagnostic and therapeutic targeting of prostate cancer U Elsässer‐Beile, P Wolf, D Gierschner, P Bühler, W Schultze‐Seemann, ... The Prostate 66 (13), 1359-1370, 2006 | 103 | 2006 |
| When monoclonal antibodies are not monospecific: Hybridomas frequently express additional functional variable regions ARM Bradbury, ND Trinklein, H Thie, IC Wilkinson, AK Tandon, ... MAbs 10 (4), 539-546, 2018 | 100 | 2018 |
| Three conformational antibodies specific for different PSMA epitopes are promising diagnostic and therapeutic tools for prostate cancer P Wolf, N Freudenberg, P Bühler, K Alt, W Schultze‐Seemann, ... The Prostate 70 (5), 562-569, 2010 | 99 | 2010 |
| Biorecognition and subcellular trafficking of HPMA copolymer− anti-PSMA antibody conjugates by prostate Cancer cells J Liu, P Kopeckova, P Bühler, P Wolf, H Pan, H Bauer, ... Molecular pharmaceutics 6 (3), 959-970, 2009 | 86 | 2009 |
| High‐resolution animal PET imaging of prostate cancer xenografts with three different 64Cu‐labeled antibodies against native cell‐adherent PSMA K Alt, S Wiehr, W Ehrlichmann, G Reischl, P Wolf, BJ Pichler, ... The Prostate 70 (13), 1413-1421, 2010 | 79 | 2010 |
| Prostate extracellular vesicles in patient plasma as a liquid biopsy platform for prostate cancer using nanoscale flow cytometry CN Biggs, KM Siddiqui, AA Al-Zahrani, S Pardhan, SI Brett, QQ Guo, ... Oncotarget 7 (8), 8839, 2016 | 78 | 2016 |
| Effective targeting of prostate cancer by lymphocytes redirected by a PSMA× CD3 bispecific single‐chain diabody K Fortmüller, K Alt, D Gierschner, P Wolf, V Baum, N Freudenberg, ... The Prostate 71 (6), 588-596, 2011 | 65 | 2011 |
| A recombinant PSMA-specific single-chain immunotoxin has potent and selective toxicity against prostate cancer cells P Wolf, D Gierschner, P Bühler, U Wetterauer, U Elsässer-Beile Cancer Immunology, Immunotherapy 55, 1367-1373, 2006 | 64 | 2006 |
| Preclinical evaluation of a recombinant anti-prostate specific membrane antigen single-chain immunotoxin against prostate cancer P Wolf, K Alt, D Wetterauer, P Bühler, D Gierschner, A Katzenwadel, ... Journal of immunotherapy 33 (3), 262-271, 2010 | 52 | 2010 |
| Target-dependent T-cell activation by coligation with a PSMA× CD3 diabody induces lysis of prostate cancer cells P Bühler, E Molnar, EP Dopfer, P Wolf, D Gierschner, U Wetterauer, ... Journal of immunotherapy 32 (6), 565-573, 2009 | 49 | 2009 |
| Splice variant transcripts of the anterior gradient 2 gene as a marker of prostate cancer A Neeb, S Hefele, S Bormann, W Parson, F Adams, P Wolf, A Miernik, ... Oncotarget 5 (18), 8681, 2014 | 46 | 2014 |
| In vitro and in vivo effects of a recombinant anti-PSMA immunotoxin in combination with docetaxel against prostate cancer M Michalska, S Schultze-Seemann, L Bogatyreva, D Hauschke, ... Oncotarget 7 (16), 22531, 2016 | 44 | 2016 |
| Antitumor activities of PSMA× CD3 diabodies by redirected T-cell lysis of prostate cancer cells V Baum, P Buehler, D Gierschner, D Herchenbach, GJ Fiala, ... Immunotherapy 5 (1), 27-38, 2013 | 44 | 2013 |
Karen AltMonash UniversityVerified email at monash.edu
